- EU study into medical AI highlights the key risks and shortcomings of legal frameworks
- Key risks posed by AI in healthcare
- Criticisms levelled at existing regulatory frameworks
- Accountability concerns
- Criticisms of the current legal risk framework
- Key takeaways
Life Sciences analysis: Harriet Hanks, senior associate, Andrew Austin, partner, and Victor Garcia Lopez, consultant, at Freshfields Bruckhaus Deringer discuss the new study from the European Parliament Parliamentary Research Service, which examines medical artificial intelligence (AI) and the particular opportunities and risks that it poses. The authors’ clear view is that AI in the healthcare domain poses specific risks that merit separate consideration from the perspective of legal frameworks and allocation of accountability. They also find the current and proposed frameworks lacking when it comes to medical AI.
Sign in or take a trial to read the full analysis.
To continue reading this news article, as well as thousands of others like it, sign in with LexisNexis or register for a free trial